Renaissance Capital logo

GIG.U News

US IPO Weekly Recap: Year's largest biotech headlines 6-IPO week

DNLI

Led by the largest biotech IPO since June 2015, six companies raised $827 million this past week. Biotech Denali Therapeutics raised $250 million, making it the largest biotech IPO of year by both deal size and market cap. The week also included pricings from a cancer biotech, a medical diagnostics company, a California bank, a payday lender and a SPAC. No companies priced...read more

Semiconducor blank check GigCapital prices downsized IPO at $10 to raise $125 million

GIG.U

GigCapital, a blank check company formed by semiconductor veteran Avi Katz to acquire a TMT business, raised $125 million by offering 12.5 million shares at $10. It originally planned to raise $150 million. Each unit consists of one share of common stock, one right to received one-tenth of one share and three-fourths of one warrant (increased from one-half) to purchase one...read more

US IPO Week Ahead: Two big biotechs lead 6-IPO week

CURO

The 2017 IPO market's final two-week sprint kicks off this week with six IPOs targeting $731 million. The week's three health care IPOs each have significant insider buying, one of which could be the year's largest biotech IPO by market cap, Denali Therapeutics. It and Odonate Therapeutics are both underwritten by Goldman Sachs, the investment...read more

GigCapital files and sets terms for $150 million IPO

GIG.U

GigCapital, a blank check company formed to acquire a TMT business, announced terms for its IPO on Wednesday. The Palo Alto, CA-based company plans to raise $150 million by offering 15 million units at a price range of $10. At pricing, GigCapital would command a fully diluted market value of $193 million. Each unit consists of one share of common stock, one right to receive one...read more

Archived Headlines